Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Beacon Biosignals
company
About
Beacon's goal is to improve human health by applying artificial intelligence to brain activity.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $27M
- Industries
- Artificial Intelligence,Health Care,Health Diagnostics,Machine Learning,Medical Device,Software
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Beacon's goal is to improve human health by applying artificial intelligence to brain activity. Beacon Biosignals delivered EEG reports with unprecedented speed and accuracy, eliminating adjudication with enhanced inclusion/exclusion criteria.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$27M
Beacon Biosignals has raised a total of
$27M
in funding over 2 rounds. Their latest funding was raised on
Nov 8, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 8, 2021 | Series A | $27M | 1 |
General Catalyst
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Beacon Biosignals is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
General Catalyst
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
